BURZYKOWSKI, Tomasz

Full Name
BURZYKOWSKI, Tomasz
Email
tomasz.burzykowski@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Date Issued:  [2000 TO 2009]

Results 81-100 of 103 (Search time: 0.004 seconds).

Issue DateTitleContributor(s)TypeCat.
812003Effect of the number of uninvolved nodes on survival in early breast cancerVinh-Hung, Vincent; Cserni, Gabor; BURZYKOWSKI, Tomasz; Van de Steene, Jan; Voordeckers, Mia; Storme, GuyJournal ContributionA1
822002Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas?Cserni, G.; Vinh-Hung, V.; BURZYKOWSKI, TomaszJournal ContributionA1
832002Post-surgery radiation in early breast cancer: survival analysis of registry dataVinh-Hung, Vincent; BURZYKOWSKI, Tomasz; Van de Steene, Jan; Storme, Guy; Soete, GuyJournal ContributionA1
842002Methodology for the validation of surrogate endpoints in multiple randomized experimentsBURZYKOWSKI, TomaszProceedings PaperC1
852002A version of the EM algorithm for proportional hazards models with random effectsCORTINAS ABRAHANTES, Jose; BURZYKOWSKI, TomaszJournal ContributionA2
862002Bayesian models in the evaluation of surrogate endpointsTORRES BARBOSA, Franz; TIBALDI, Fabian; CORTINAS ABRAHANTES, Jose; BURZYKOWSKI, Tomasz; GEYS, Helena; Allende, S.; MOLENBERGHS, GeertProceedings PaperC2
872002Statistical challenges in the evaluation of surrogate endpoints in randomized trialsMOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, Didier; BURZYKOWSKI, Tomasz; ALONSO ABAD, ArielJournal ContributionA1
882002Challenges in the methodology for the validation of surrogate endpoints in randomized trialsMOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, Didier; BURZYKOWSKI, TomaszProceedings PaperC2
892002Validation of surrogate endpoints in multiple randomized clinical trials with discrete outcomesRENARD, Didier; GEYS, Helena; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
902001Validation of surrogate endpoints from multiple randomized clinical trials with a failure-time true endpointBURZYKOWSKI, TomaszTheses and DissertationsT1
912001Strong association between p53 protein accumulation, serum antibodies and gene mutation in non-small cell lung cancerNiklinska, W.; BURZYKOWSKI, Tomasz; Chyczewski, L.; Laudanski, J.; Niklinski, J.Journal ContributionA1
922001Methodology for the validation of surrogate endpoints in multiple randomized experimentsMOLENBERGHS, Geert; ALONSO ABAD, Ariel; BURZYKOWSKI, Tomasz; CORTINAS ABRAHANTES, Jose; GEYS, Helena; RENARD, Didier; SHKEDY, Ziv; TIBALDI, Fabian; BUYSE, MarcProceedings PaperC2
932001Methodology of the validation of surrogate endpoints in multiple randomized experimentsMOLENBERGHS, Geert; ALONSO ABAD, Ariel; BURZYKOWSKI, Tomasz; CORTINAS ABRAHANTES, Jose; GEYS, Helena; RENARD, Didier; SHKEDY, Ziv; TIBALDI, Fabian; BUYSE, MarcProceedings PaperC2
942001Expression of vascular endothelial growth factor (VEGF) in non-small cell lung cancer (NSCLC): association with p53 gene mutation and prognosisNiklinska, W.; BURZYKOWSKI, Tomasz; Chyczewski, L.; Niklinski, JacekJournal ContributionA1
952001Validation of surrogate endpoints in multiple randomized clinical trials with failure-time endpointsBURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, DidierJournal ContributionA1
962001Re: A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancerBUYSE, Marc; Thirion, Pierre; Carlson, Robert; BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; Piedbois, PascalJournal ContributionA1
972001Prognostic significance of p53 and bcl-2 abnormalities in operable non-small cell lung cancerLaudanski, J.; Niklinska, W.; BURZYKOWSKI, Tomasz; Chyczewski, L.; Niklinski, J.Journal ContributionA1
982000P53 gene mutation and protein expression in operable non-small cell lung cancer in PolandNiklinska, W.; BURZYKOWSKI, Tomasz; Chyczewski, L.; Rusin, M. R.; Furman, M.; Laudanski, J.; Chyczewska, E.; Sulik, M.; Niklinski, JacekJournal ContributionA1
992000Validation of surrogate endpoints in multiple randomized clinical trials with failure-time endpointsBURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, DidierProceedings PaperC1
1002000Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysisBUYSE, Marc; Thirion, Pierre; Carlson, Robert W.; BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; Piedbois, PascalJournal ContributionA1